Logo

Combination therapy found safe and beneficial for acute myeloid leukemia patients with specific genetic profile

Combination therapy found safe and beneficial for acute myeloid leukemia patients with specific genetic profile

A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia (AML) showed high rates of complete remission in an early-phase clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and 11 other sites nationwide.

👉 Full Story